SBI Life Share Price: Why Morgan Stanley sees 24% upside ahead of Q4 results?

Shares of SBI Life Insurance Company are likely to remain in focus ahead of its March-quarter results, with brokerage firm Morgan Stanley maintaining an “Overweight” rating on the stock and highlighting limited regulatory risks.

The Mumbai-headquartered Insurer is set to report its financial results for the January-March period today, Tuesday, April 22.

The brokerage said investors have raised concerns around potential regulatory risks from the introduction of mandatory open architecture for banks. However, it advised against second-guessing regulation and outlined key factors suggesting that the risk of adverse outcomes remains limited.

Why Morgan Stanley is Bullish on SBI Life?

According to Morgan Stanley, the Reserve Bank of India’s recent draft norms do not mandate open architecture. Instead, they require customers to be given a choice of provider, including insurance, only in cases where products are mandatorily bundled.

At a press meet in February 2026, Reserve Bank of India Governor had said instances of mis-selling remain low, while emphasising the need to safeguard customer interests.

The brokerage noted that SBI Life’s mis-selling ratio is consistently among the lowest in the industry. It added that the parent-subsidiary structure between SBI and SBI Life provides better control over sales practices.

Morgan Stanley also said SBI Life’s low-cost base is supported by its closed bancassurance architecture. A shift towards open architecture could lead to higher costs, as moving sales to non-bank staff would increase both commission and non-commission expenses.

It further noted that if the policy objective is to reduce commissions for customer benefit, industry experience suggests that open architecture could instead lead to higher commission costs.

At the current market price of Rs 1,911, Morgan Stanley has set a target price of Rs 2,375, implying a potential upside of about 24 per cent.

Q4 earnings preview

SBI Life Insurance is scheduled to report its results for the January–March quarter on April 22. Analysts expect a mixed performance, with growth in premium income but a slight decline in profit.

According to Zee Business estimates, the insurer is likely to report a net profit of Rs 790 crore for the quarter, compared with Rs 813.5 crore in the year-ago period, marking a decline of about 2.9 per cent.

Gross premium income, a key revenue metric, is estimated to rise 12 per cent year-on-year to Rs 26,900 crore.

The company’s new business annualised premium equivalent (APE) is pegged at Rs 5,880 crore for the quarter, up 8 per cent on a yearly basis.

Value of new business (VNB) margin is estimated at 28.4 per cent, compared with 30.5 per cent a year ago. The margin is expected to remain under pressure due to input tax credit-related changes, though it could still be the best quarterly margin for FY26.

Analysts said they will closely track the insurer’s product mix and new offerings in the upcoming results.

SBI Life Q3 Results

SBI Life Insurance Company reported a 5 per cent rise in net profit at Rs 577 crore for the third quarter ended December 2025, compared with Rs 551 crore in the year-ago period.

Net premium income increased to Rs 30,245 crore from Rs 24,828 crore a year earlier, according to a regulatory filing. Total income more than doubled to Rs 45,803 crore during the quarter from Rs 18,542 crore in the corresponding period last fiscal, driven by investment income of Rs 15,531 crore as against a negative return of Rs 6,282 crore a year ago.

The solvency ratio declined to 191 per cent as on December 31, 2025, from 204 per cent a year ago, though it remained above the regulatory requirement of 150 per cent.

Assets under management grew 19 per cent year-on-year to Rs 5,11,710 crore from Rs 4,41,678 crore, with a debt-equity mix of 51:49.